TOKYO -- The vaccines now offering the world potential exits from the yearlong coronavirus pandemic are having bearish effects on the gold market.
The New York benchmark price for the haven asset on Nov. 30 was at $1,790 per ounce, down 13% from Aug. 6, when it was at a record $2,069. On Dec. 10, the price sat near $1,838.
